Plasmid-Mediated Spread of Carbapenem Resistance in Enterobacterales: A Three-Year Genome-Based Survey

Yancheng Yao1,2, Can Imirzalioglu1,2, Linda Falgenhauer1,3,4

  • 1Institute of Medical Microbiology, Justus Liebig University Giessen, Schubertstrasse 81, 35392 Giessen, Germany.

PubMed

Insights

Carbapenem-resistant Gram-negative bacteria (CRGNB) pose a significant threat. Plasmids are key drivers in spreading carbapenem resistance among CRGNB, impacting healthcare and orthopedic surgery.

Area of Science:

  • Medical Microbiology
  • Genomics
  • Antimicrobial Resistance

Background:

  • Carbapenem-resistant Gram-negative bacteria (CRGNB) represent a critical global health challenge due to limited treatment options and high mortality rates.
  • The emergence of carbapenemases, such as KPC, NDM, VIM, and OXA-48, in Gram-negative bacteria necessitates robust surveillance and understanding of resistance mechanisms.

Purpose of the Study:

  • To conduct a genome-based surveillance of CRGNB in Hesse, Germany, from 2017-2019.
  • To characterize the landscape of carbapenem resistance determinants and their genetic elements, particularly plasmids, within CRGNB isolates.

Main Methods:

  • Genome-based surveillance utilizing next-generation sequencing (NGS) on 589 CRGNB isolates from 61 hospitals.
  • Analysis of carbapenemase genes and plasmid incompatibility (Inc) types in 520 Enterobacterales isolates.

Main Results:

  • Over 80% of detected carbapenem resistance determinants in Enterobacterales were plasmid-encoded, with IncN, IncL/M, IncFII, and IncF(K) types being predominant.
  • Plasmids were identified as major facilitators of carbapenem resistance dissemination across multiple species and were linked to local outbreaks.
  • Predominant CRGNB included Klebsiella pneumoniae, Escherichia coli, Citrobacter freundii, and Acinetobacter baumannii.

Conclusions:

  • Plasmids play a crucial role in the spread of carbapenem resistance within the CRGNB population through horizontal gene transfer.
  • Understanding plasmid-mediated resistance is vital for combating CRGNB infections, including those affecting orthopedic implants.
  • Future genomic surveillance should prioritize detailed plasmid characterization to better track and control antimicrobial resistance spread.